MetLife Investment Management’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-52,011
| Closed | -$3.93M | – | 2914 |
|
|
2026
Q1 | $3.93M | Sell |
52,011
-1,349
| -3% | -$101K | 0.02% | 736 |
|
|
2025
Q4 | $3.97M | Sell |
53,360
-1,835
| -3% | -$134K | 0.02% | 735 |
|
|
2025
Q3 | $3.73M | Sell |
55,195
-1,587
| -3% | -$105K | 0.02% | 768 |
|
|
2025
Q2 | $3.7M | Sell |
56,782
-1,458
| -3% | -$87.4K | 0.02% | 701 |
|
|
2025
Q1 | $3.6M | Sell |
58,240
-3,169
| -5% | -$210K | 0.02% | 773 |
|
|
2024
Q4 | $4.43M | Buy |
61,409
+1,080
| +2% | +$84.4K | 0.02% | 631 |
|
|
2024
Q3 | $4.91M | Sell |
60,329
-1,877
| -3% | -$150K | 0.03% | 538 |
|
|
2024
Q2 | $4.62M | Buy |
62,206
+7,314
| +13% | +$548K | 0.03% | 531 |
|
|
2024
Q1 | $4.28M | Sell |
54,892
-4,527
| -8% | -$337K | 0.03% | 578 |
|
|
2023
Q4 | $4.25M | Sell |
59,419
-1,123
| -2% | -$78.2K | 0.03% | 567 |
|
|
2023
Q3 | $4.2M | Sell |
60,542
-1,860
| -3% | -$141K | 0.03% | 505 |
|
|
2023
Q2 | $5.05M | Sell |
62,402
-1,152
| -2% | -$94.1K | 0.04% | 434 |
|
|
2023
Q1 | $5.13M | Sell |
63,554
-1,566
| -2% | -$126K | 0.04% | 431 |
|
|
2022
Q4 | $4.87M | Sell |
65,120
-1,067
| -2% | -$76K | 0.04% | 450 |
|
|
2022
Q3 | $4.27M | Sell |
66,187
-919
| -1% | -$63.7K | 0.04% | 489 |
|
|
2022
Q2 | $4.65M | Sell |
67,106
-859
| -1% | -$63.8K | 0.04% | 464 |
|
|
2022
Q1 | $5.22M | Buy |
67,965
+11,960
| +21% | +$860K | 0.03% | 496 |
|
|
2021
Q4 | $4.29M | Sell |
56,005
-1,246
| -2% | -$91.6K | 0.04% | 477 |
|
|
2021
Q3 | $4.23M | Sell |
57,251
-2,155
| -4% | -$162K | 0.04% | 459 |
|
|
2021
Q2 | $3.96M | Sell |
59,406
-1,994
| -3% | -$133K | 0.03% | 515 |
|
|
2021
Q1 | $4.57M | Sell |
61,400
-1,015
| -2% | -$77.1K | 0.04% | 436 |
|
|
2020
Q4 | $4.55M | Sell |
62,415
-3,248
| -5% | -$229K | 0.04% | 403 |
|
|
2020
Q3 | $4.36M | Sell |
65,663
-1,866
| -3% | -$118K | 0.05% | 361 |
|
|
2020
Q2 | $3.85M | Sell |
67,529
-1,588
| -2% | -$77.9K | 0.04% | 401 |
|
|
2020
Q1 | $2.43M | Sell |
69,117
-2,115
| -3% | -$101K | 0.03% | 530 |
|
|
2019
Q4 | $3.72M | Sell |
71,232
-1,511
| -2% | -$75.2K | 0.04% | 506 |
|
|
2019
Q3 | $3.67M | Sell |
72,743
-1,142
| -2% | -$56.2K | 0.04% | 484 |
|
|
2019
Q2 | $3.55M | Sell |
73,885
-2,234
| -3% | -$103K | 0.04% | 525 |
|
|
2019
Q1 | $3.68M | Sell |
76,119
-926
| -1% | -$41.8K | 0.04% | 505 |
|
|
2018
Q4 | $3.17M | Sell |
77,045
-2,115
| -3% | -$86.8K | 0.04% | 518 |
|
|
2018
Q3 | $3.24M | Sell |
79,160
-1,208
| -2% | -$48.8K | 0.03% | 617 |
|
|
2018
Q2 | $3.19M | Sell |
80,368
-2,850
| -3% | -$110K | 0.04% | 564 |
|
|
2018
Q1 | $3.11M | Sell |
83,218
-2,080
| -2% | -$84K | 0.04% | 588 |
|
|
2017
Q4 | $3.65M | Buy |
+85,298
| New | +$3.4M | 0.04% | 520 |
|
Other funds holding HOLX
MetLife Investment Management's HOLX Position: Q2 2026 in Review
MetLife Investment Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 52,011 shares — an estimated $3.93M sold.
MetLife Investment Management first reported a position in HOLX in Q4 2017 and held it in 34 quarters. The position peaked at $5.22M in Q1 2022. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- MetLife Investment Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- MetLife Investment Management sold 52,011 Hologic shares in Q2 2026, an estimated $3.93M.
- MetLife Investment Management first reported a position in Hologic in Q4 2017 and held it in 34 quarters.
- MetLife Investment Management's Hologic position peaked at $5.22M in Q1 2022.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.